Akanda (AKAN) Cash & Current Investments (2020 - 2025)
Akanda's (AKAN) quarterly Cash & Current Investments came in at $503562.0 in Q4 2025, down 86.89% YoY from $3.8 million in Q4 2024, and down 86.91% on a QoQ basis from $3.8 million in Q2 2025.
Akanda (AKAN) Cash & Current Investments (2020 - 2025) Analysis & Trends
Akanda's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $503562.0 for Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 86.89% year-over-year to $503562.0 in Q4 2025; TTM through Dec 2025 was $503562.0, a 86.89% decrease from a year earlier, with the FY2025 full-year figure at $503562.0, down 86.89% from the prior year.
- Cash & Current Investments was $503562.0 for Q4 2025 at Akanda, down from $3.8 million in the prior quarter.
- Over the last five years, Cash & Current Investments for AKAN reached as high as $4.4 million in Q2 2022 and fell as low as $104934.0 in Q4 2023.
- A 5-year average of $1.9 million and a median of $503562.0 in 2025 frame the typical range for Cash & Current Investments.
- The widest annual swing landed in 2021, when Cash & Current Investments surged 25784.11%; it then tumbled 94.19% in 2023.
- Tracing AKAN's Cash & Current Investments over 5 years: stood at $3.5 million in 2021, then slumped by 91.91% to $282812.0 in 2022, then sank by 62.9% to $104934.0 in 2023, then soared by 3561.22% to $3.8 million in 2024, then slumped by 86.89% to $503562.0 in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $503562.0, $3.8 million, and $3.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Akanda | 996.67 Mn | 996.17 Mn | - | 503,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 503,562.00 |
| Jun 30, 2025 | 3.85 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Jun 30, 2024 | 112,595.00 |
| Dec 31, 2023 | 104,934.00 |
| Jun 30, 2023 | 255,803.00 |
| Dec 31, 2022 | 282,812.00 |
| Jun 30, 2022 | 4.40 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 13,504.00 |